Commentary on Some Recent Theses Relevant to Combating Aging: June 2021

Insights

This review covers advancements in protein disaggregases for neurodegenerative diseases, immunomodulation in diabetes, and microvasculature-on-a-chip models. It also explores immune system surveillance of senescent cells and T cell exhaustion in cancer.

Area of Science:

  • Biomedical Engineering
  • Immunology
  • Cellular Biology
  • Translational Medicine

Background:

  • Neurodegenerative diseases like Alzheimer's and Parkinson's involve protein aggregation.
  • Diabetic vascular disease is linked to altered macrophage function.
  • Human disease modeling benefits from advanced in vitro systems.
  • Cellular senescence plays a role in aging and disease.
  • T cell exhaustion impairs anti-tumor and anti-pathogen immunity.
  • Xenotransplantation holds promise for organ shortages.

Purpose of the Study:

  • To summarize recent theses and advancements in key areas of biomedical research.
  • To highlight novel approaches in disease modeling and therapeutic development.
  • To provide an overview of cutting-edge research across multiple scientific disciplines.

Main Methods:

  • Engineering protein disaggregases to target toxic protein aggregates.
  • Investigating the effects of hyperglycemia on macrophage immunomodulation.
  • Developing and utilizing microvasculature-on-a-chip systems.
  • Analyzing the interplay between the immune system and senescent cells.
  • Studying the role of transcription factor TOX in T cell exhaustion.
  • Exploring translational progress in xenotransplantation.

Main Results:

  • Protein disaggregases show potential against alpha-synuclein and amyloid-beta toxicity.
  • Hyperglycemia modulates macrophage behavior in diabetic vascular contexts.
  • Microvasculature-on-a-chip systems offer new avenues for disease modeling.
  • Immune surveillance mechanisms for senescent cells are being elucidated.
  • TOX drives a program of CD8+ T cell exhaustion.
  • Significant translational advancements are being made in xenotransplantation.

Conclusions:

  • Engineering protein disaggregases offers a novel therapeutic strategy for neurotoxicity.
  • Understanding macrophage immunomodulation is crucial for managing diabetic vascular complications.
  • Microvasculature-on-a-chip technology advances human disease modeling.
  • Senescence surveillance is a critical area linking immunity and aging.
  • Targeting TOX may reinvigorate T cell responses in chronic infections and cancer.
  • Xenotransplantation is moving closer to clinical application.

Related Concept Videos

The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.9K
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
16.9K
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
381
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
57
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.0K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
44